Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant

Recruiting

Phase 2

Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant

Sponsor:

Children's Hospital Medical Center, Cincinnati

Code:

NCT05579639

Conditions

Allogeneic Stem Cell Transplantation

Eligibility Criteria

Sex: All

Age: 4 - 25

Healthy Volunteers: Not accepted

Interventions

Xylitol

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information